KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Finished Goods (2018 - 2025)

Globus Medical's Finished Goods history spans 8 years, with the latest figure at $555.7 million for Q3 2025.

  • For Q3 2025, Finished Goods changed 0.46% year-over-year to $555.7 million; the TTM value through Sep 2025 reached $555.7 million, changed 0.46%, while the annual FY2024 figure was $491.5 million, 30.53% down from the prior year.
  • Finished Goods reached $555.7 million in Q3 2025 per GMED's latest filing, roughly flat from $558.4 million in the prior quarter.
  • In the past five years, Finished Goods ranged from a high of $769.7 million in Q3 2023 to a low of $172.1 million in Q3 2021.
  • Average Finished Goods over 5 years is $390.0 million, with a median of $237.4 million recorded in 2023.
  • Peak YoY movement for Finished Goods: surged 273.12% in 2023, then tumbled 30.53% in 2024.
  • A 5-year view of Finished Goods shows it stood at $177.8 million in 2021, then rose by 23.72% to $220.0 million in 2022, then skyrocketed by 221.64% to $707.5 million in 2023, then crashed by 30.53% to $491.5 million in 2024, then rose by 13.08% to $555.7 million in 2025.
  • Per Business Quant, the three most recent readings for GMED's Finished Goods are $555.7 million (Q3 2025), $558.4 million (Q2 2025), and $497.0 million (Q1 2025).